<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font28">the </span>
   <span class="font15">with </span>
   <span class="font15">for </span>
   <span class="font14">Ar-H), </span>
   <span class="font13">cell </span>
   <span class="font13">.â€‰Â±â€‰. </span>
   <span class="font13">(m, </span>
   <span class="font13">.â€". </span>
   <span class="font13">activity </span>
   <span class="font13">cancer </span>
   <span class="font12">CDK </span>
   <span class="font12">The </span>
   <span class="font12">were </span>
   <span class="font12">breast </span>
   <span class="font12">kinase </span>
   <span class="font12">compounds </span>
   <span class="font12">Jâ€‰=â€‰.â€‰Hz), </span>
   <span class="font12">inhibitors </span>
   <span class="font12">GSK-Î² </span>
   <span class="font12">their </span>
   <span class="font12">Med </span>
   <span class="font11">âˆ’. </span>
   <span class="font11">Chem;:â€". </span>
   <span class="font11">(â€‰s, </span>
   <span class="font11">Ar-H, </span>
   <span class="font11">respectively, </span>
   <span class="font11">showed </span>
   <span class="font11">was </span>
   <span class="font11">potent </span>
   <span class="font11">(s, </span>
   <span class="font11">NMR </span>
   <span class="font11">docking </span>
   <span class="font11">which </span>
   <span class="font11">{background </span>
   <span class="font11">ppm: </span>
   <span class="font11">cells </span>
   <span class="font11">oxindole </span>
   <span class="font11">MCF- </span>
   <span class="font11">derivatives </span>
   <span class="font11">its </span>
   <span class="font11">(d, </span>
   <span class="font11">key </span>
   <span class="font11">target </span>
   <span class="font11">anticancer </span>
   <span class="font11">binding </span>
   <span class="font11">dual </span>
   <span class="font11">â€" </span>
   <span class="font11">margin </span>
   <span class="font11">through </span>
   <span class="font11">(Câ€‰=â€‰O </span>
   <span class="font11">(t, </span>
   <span class="font11">from </span>
   <span class="font11">indolin--one), </span>
   <span class="font11">inhibitory </span>
   <span class="font11">kinases </span>
   <span class="font11">that </span>
   <span class="font11">{border-style </span>
   <span class="font11">biological </span>
   <span class="font11">calculated </span>
   <span class="font11">cytotoxic </span>
   <span class="font11">found </span>
   <span class="font10">%), </span>
   <span class="font10">(yield </span>
   <span class="font10">..... </span>
   <span class="font10">Analysis </span>
   <span class="font10">active </span>
   <span class="font10">m.p. </span>
   <span class="font10">molecular </span>
   <span class="font10">powder </span>
   <span class="font10">protein </span>
   <span class="font10">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">(KBr, </span>
   <span class="font10">(NH) </span>
   <span class="font10">(â€‰Câ€‰=â€‰O); </span>
   <span class="font10">cmâˆ’) </span>
   <span class="font10">hybrids </span>
   <span class="font10">inhibition </span>
   <span class="font10">inhibitors. </span>
   <span class="font10">isatin </span>
   <span class="font10">CDK/GSK-Î² </span>
   <span class="font10">amino </span>
   <span class="font10">synthase </span>
   <span class="font10">used </span>
   <span class="font10">CHBrNO: </span>
   <span class="font10">Eur </span>
   <span class="font10">Table </span>
   <span class="font10">both </span>
   <span class="font10">cycle </span>
   <span class="font10">Cancer </span>
   <span class="font10">Figure </span>
   <span class="font10">NH); </span>
   <span class="font10">are </span>
   <span class="font10">cyclin-dependent </span>
   <span class="font10">synthesised </span>
   <span class="font10">treatment </span>
   <span class="font10">T-D </span>
   <span class="font10">anti-proliferative </span>
   <span class="font10">cancer. </span>
   <span class="font10">derivative </span>
   <span class="font10">further </span>
   <span class="font10">human </span>
   <span class="font10">novel </span>
   <span class="font10">series </span>
   <span class="font10">.H, </span>
   <span class="font10">.], </span>
   <span class="font10">Compounds </span>
   <span class="font10">GSK-Î². </span>
   <span class="font10">[M, </span>
   <span class="font10">inÂ </span>
   <span class="font10">several </span>
   <span class="font10">studies </span>
   <span class="font10">such </span>
   <span class="font10">Val, </span>
   <span class="font10">acids </span>
   <span class="font10">evaluation </span>
   <span class="font10">glycogen </span>
   <span class="font10">hinge </span>
   <span class="font10">hydrophobic </span>
   <span class="font10">interaction </span>
   <span class="font10">potential </span>
   <span class="font10">â€"â€‰Â°C; </span>
   <span class="font10">â€‰C </span>
   <span class="font10">â€‰h, </span>
   <span class="font10">Bioorg </span>
   <span class="font10">antiproliferative </span>
   <span class="font10">apoptosis </span>
   <span class="font10">backbone </span>
   <span class="font10">cellular </span>
   <span class="font10">co-crystallized </span>
   <span class="font10">effect </span>
   <span class="font10">lines </span>
   <span class="font10">moderate </span>
   <span class="font10">newly </span>
   <span class="font10">promising </span>
   <span class="font10">synthesis, </span>
   <span class="font10">well </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">(Table </span>
   <span class="font10">G/M </span>
   <span class="font10">Leu, </span>
   <span class="font10">Yellow </span>
   <span class="font10">apoptotic </span>
   <span class="font10">cyclin </span>
   <span class="font10">group </span>
   <span class="font10">interactions </span>
   <span class="font10">phase </span>
   <span class="font10">pose </span>
   <span class="font10">reference </span>
   <span class="font10">region </span>
   <span class="font10">respectively. </span>
   <span class="font10">results </span>
   <span class="font10">selectivity </span>
   <span class="font10">showing </span>
   <span class="font10">study </span>
   <span class="font10">synthesis </span>
   <span class="font10">towards </span>
   <span class="font10">vitro </span>
   <span class="font10">Asp </span>
   <span class="font10">CDK, </span>
   <span class="font10">Cell </span>
   <span class="font10">EldehnaWM, </span>
   <span class="font10">Enzyme </span>
   <span class="font10">ID: </span>
   <span class="font10">Leu </span>
   <span class="font10">Synthesis </span>
   <span class="font10">activities </span>
   <span class="font10">agents. </span>
   <span class="font10">bonding </span>
   <span class="font10">growth </span>
   <span class="font10">hydrazide); </span>
   <span class="font10">hydrogen </span>
   <span class="font10">inhibitor </span>
   <span class="font10">nucleus </span>
   <span class="font10">px; </span>
   <span class="font10">role </span>
   <span class="font10">tyrosine </span>
   <span class="font10">{font-family </span>
   <span class="font10">â€‰D </span>
   <span class="font10">(Figure </span>
   <span class="font10">(IC </span>
   <span class="font10">.â€‰Î¼M, </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Glu </span>
   <span class="font10">PKs </span>
   <span class="font10">against </span>
   <span class="font10">al.Novel </span>
   <span class="font10">arrest </span>
   <span class="font10">assay </span>
   <span class="font10">cells. </span>
   <span class="font10">could </span>
   <span class="font10">font-size </span>
   <span class="font10">have </span>
   <span class="font10">hybrid </span>
   <span class="font10">interacts </span>
   <span class="font10">most </span>
   <span class="font10">reaction </span>
   <span class="font10">ring </span>
   <span class="font10">solution </span>
   <span class="font10">structure </span>
   <span class="font10">targeting </span>
   <span class="font10">tested </span>
   <span class="font10">than </span>
   <span class="font10">then </span>
   <span class="font10">therapeutic </span>
   <span class="font10">two </span>
   <span class="font10">â€‰Â°C; </span>
   <span class="font10">(PDB </span>
   <span class="font10">... </span>
   <span class="font10">.â€‰nM, </span>
   <span class="font10">Chemistry, </span>
   <span class="font10">GSK-Î², </span>
   <span class="font10">KerdawyAM, </span>
   <span class="font10">Mol </span>
   <span class="font10">Molecular </span>
   <span class="font10">Moreover, </span>
   <span class="font10">N-CH), </span>
   <span class="font10">N-CH-CH), </span>
   <span class="font10">N-unsubstituted </span>
   <span class="font10">Nat </span>
   <span class="font10">RMSD </span>
   <span class="font10">Res;:â€". </span>
   <span class="font10">Val </span>
   <span class="font10">[%]: </span>
   <span class="font10">[]; </span>
   <span class="font10">acid </span>
   <span class="font10">been </span>
   <span class="font10">benzofuran </span>
   <span class="font10">comparison </span>
   <span class="font10">designed </span>
   <span class="font10">discovery </span>
   <span class="font10">double; </span>
   <span class="font10">factor </span>
   <span class="font10">inhibitors: </span>
   <span class="font10">involved </span>
   <span class="font10">kinase- </span>
   <span class="font10">kinases. </span>
   <span class="font10">lines, </span>
   <span class="font10">m/z </span>
   <span class="font10">mixture </span>
   <span class="font10">moiety </span>
   <span class="font10">moreover, </span>
   <span class="font10">other </span>
   <span class="font10">performed </span>
   <span class="font10">phase, </span>
   <span class="font10">phosphorylation </span>
   <span class="font10">receptor </span>
   <span class="font10">reported </span>
   <span class="font10">score </span>
   <span class="font10">selective </span>
   <span class="font10">side </span>
   <span class="font10">site </span>
   <span class="font10">these </span>
   <span class="font10">under </span>
   <span class="font10">using </span>
   <span class="font10">weak </span>
   <span class="font10">â€‰g </span>
   <span class="font10">â€‰h </span>
   <span class="font10">(S) </span>
   <span class="font10">.,. </span>
   <span class="font10">.... </span>
   <span class="font10">.â€‰ÂµM, </span>
   <span class="font10">All </span>
   <span class="font10">Apoptosis </span>
   <span class="font10">Comp. </span>
   <span class="font10">Department </span>
   <span class="font10">Faculty </span>
   <span class="font10">GSK </span>
   <span class="font10">GSK- </span>
   <span class="font10">Orange </span>
   <span class="font10">Pharmaceutical </span>
   <span class="font10">Pharmacy, </span>
   <span class="font10">Protein </span>
   <span class="font10">Scheme </span>
   <span class="font10">acids; </span>
   <span class="font10">action </span>
   <span class="font10">activity. </span>
   <span class="font10">afford </span>
   <span class="font10">agents </span>
   <span class="font10">al.The </span>
   <span class="font10">attributed </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">co-crystalized </span>
   <span class="font10">compared </span>
   <span class="font10">compound </span>
   <span class="font10">control </span>
   <span class="font10">details, </span>
   <span class="font10">early </span>
   <span class="font10">endothelial </span>
   <span class="font10">increase </span>
   <span class="font10">inhibition. </span>
   <span class="font10">intermediate </span>
   <span class="font10">ligands </span>
   <span class="font10">lines. </span>
   <span class="font10">materials). </span>
   <span class="font10">mechanism </span>
   <span class="font10">more </span>
   <span class="font10">new </span>
   <span class="font10">progression </span>
   <span class="font10">proliferation </span>
   <span class="font10">range </span>
   <span class="font10">relationship </span>
   <span class="font10">see </span>
   <span class="font10">solid </span>
   <span class="font10">solid; </span>
   <span class="font10">standard </span>
   <span class="font10">staurosporine </span>
   <span class="font10">supporting </span>
   <span class="font10">targeted </span>
   <span class="font10">tumour </span>
   <span class="font10">washed </span>
   <span class="font10">what </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">â€‰b </span>
   <span class="font10">(A) </span>
   <span class="font10">(B) </span>
   <span class="font10">(Figures </span>
   <span class="font10">(such </span>
   <span class="font10">.â€‰mmol) </span>
   <span class="font10">Ala, </span>
   <span class="font10">Benzofuran </span>
   <span class="font10">CDK- </span>
   <span class="font10">Cancer;:â€". </span>
   <span class="font10">Chem </span>
   <span class="font10">Chem;:. </span>
   <span class="font10">Clin </span>
   <span class="font10">Drug </span>
   <span class="font10">Ile, </span>
   <span class="font10">Inhibit </span>
   <span class="font10">Lett;:â€". </span>
   <span class="font10">MTT </span>
   <span class="font10">N-CH, </span>
   <span class="font10">Phe, </span>
   <span class="font10">Rev </span>
   <span class="font10">These </span>
   <span class="font10">agents: </span>
   <span class="font10">al.Design, </span>
   <span class="font10">amount </span>
   <span class="font10">analogue </span>
   <span class="font10">approach </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">bromo </span>
   <span class="font10">bulk </span>
   <span class="font10">cancer, </span>
   <span class="font10">cancers </span>
   <span class="font10">chains </span>
   <span class="font10">common </span>
   <span class="font10">comparable </span>
   <span class="font10">courier; </span>
   <span class="font10">derivatives, </span>
   <span class="font10">design, </span>
   <span class="font10">despite </span>
   <span class="font10">development </span>
   <span class="font10">diagram </span>
   <span class="font10">different </span>
   <span class="font10">diseases </span>
   <span class="font10">drug </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">family </span>
   <span class="font10">formed </span>
   <span class="font10">functions </span>
   <span class="font10">furnish </span>
   <span class="font10">hand, </span>
   <span class="font10">heated </span>
   <span class="font10">hinder </span>
   <span class="font10">hot </span>
   <span class="font10">hydrate </span>
   <span class="font10">hydrazine </span>
   <span class="font10">indicated </span>
   <span class="font10">interacting </span>
   <span class="font10">late </span>
   <span class="font10">ligand </span>
   <span class="font10">line </span>
   <span class="font10">low </span>
   <span class="font10">methoxy </span>
   <span class="font10">multikinase </span>
   <span class="font10">out </span>
   <span class="font10">overexpression </span>
   <span class="font10">patterns </span>
   <span class="font10">prepared </span>
   <span class="font10">presented </span>
   <span class="font10">produce </span>
   <span class="font10">pt;} </span>
   <span class="font10">rationalise </span>
   <span class="font10">recrystallized </span>
   <span class="font10">serine/threonine </span>
   <span class="font10">show </span>
   <span class="font10">signalling </span>
   <span class="font10">silico </span>
   <span class="font10">site. </span>
   <span class="font10">small </span>
   <span class="font10">solvent </span>
   <span class="font10">staining </span>
   <span class="font10">structures </span>
   <span class="font10">studies. </span>
   <span class="font10">substituent </span>
   <span class="font10">surrounding </span>
   <span class="font10">therefore, </span>
   <span class="font10">three </span>
   <span class="font10">via </span>
   <span class="font10">water </span>
   <span class="font10">whereas, </span>
  </p>
 </body>
</html>
